Clinical Trial Update: A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib [Phase 3]

View source ↗

Summary

Phase 3 clinical trial updating the evaluation of molecular-guided therapy for diffuse large B-cell lymphoma with Bortezomib has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: University Hospital Southampton NHS Foundation Trust | Conditions: Lymphoma, Large B-Cell, Diffuse | Phase 3 | Status: COMPLETED